Two Sigma Securities, LLC Moderna, Inc. Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

A detailed history of Two Sigma Securities, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 84,500 shares of MRNA stock, worth $3.33 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

84,500

Previous 85,900 1.63%

Holding current value

$3.33 Million

Previous $10.2 Million 44.64%

% of portfolio

0.1%

Previous 0.12%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $344,665 - $452,630	-3,575 Reduced 30.04%	8,326 $859,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $4.57 Million - $6.18 Million	-38,525 Reduced 76.4%	11,901 $1.45 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $1.33 Million - $1.93 Million	9,813 Added 24.16%	50,426 $7.74 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $760,946 - $1.35 Million	-6,428 Reduced 13.66%	40,613 $7.29 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $2.64 Million - $4.34 Million	22,343 Added 90.46%	47,041 $5.56 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $1.23 Million - $1.85 Million	-10,495 Reduced 29.82%	24,698 $3.53 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $4.16 Million - $7.73 Million	32,887 Added 1426.15%	35,193 $6.06 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $152,428 - $248,744	-675 Reduced 22.64%	2,306 $586,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $760,451 - $1.66 Million	-3,427 Reduced 53.48%	2,981 $1.15 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $495,346 - $895,978	3,813 Added 146.94%	6,408 $1.51 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $44,436 - $75,693	-407 Reduced 13.56%	2,595 $340,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $197,351 - $509,919	3,002 New	3,002 $314,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account

Two Sigma Securities, LLC Moderna, Inc. Transaction History